Can abnormal evoked potentials predict future clinical disability in patients with multiple sclerosis?
Frank L Mastaglia
Correspondence Centre for Neuromuscular and Neurological Disorders, 4th Floor, A Block, Queen Elizabeth II Medical Centre, Nedlands, WA 6009, Australia
Email flmast@cyllene.uwa.edu.au
This article has no abstract so we have provided the first paragraph of the full text.
The clinical course of patients with MS is extremely variable, and predicting the likelihood of progression and the eventual degree of disability is difficult in the early stages of the disease. Certain features such as the age at onset, the area of the CNS initially affected (e.g. spinal cord, brainstem, cerebellum) and the frequency of relapses in the first 2 years of the illness can give some guide to the subsequent course of disease.1 The number and volume of brain lesions on MRI have also been shown to be of some prognostic value.2 None of these criteria, however, are sufficiently reliable in their own right to predict what the future holds for an individual patient.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.